| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $176.2M | +58.3% |
| R&D Expense | $234.1M | -6.3% |
| SG&A Expense | $61.2M | -2.4% |
| Operating Income | -$274.0M | -36.1% |
| Pre-tax Income | -$262.9M | -37.0% |
| Income Tax | -$5.1M | -1282.3% |
| Net Income | -$257.8M | -34.1% |
| EPS (Basic) | -$1.48 | -18.4% |
| EPS (Diluted) | -$1.48 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.2M | -55.0% |
| Accounts Receivable | $923K | -74.9% |
| Current Assets | $94.3M | -68.6% |
| Total Assets | $165.3M | -70.6% |
| Current Liabilities | $47.7M | -57.3% |
| Total Liabilities | $82.4M | -69.2% |
| Stockholders' Equity | $82.9M | -71.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$224.8M | -0.5% |
| Capital Expenditures | $21.2M | +4.9% |
| Investing Cash Flow | $153.5M | +159.0% |
| Financing Cash Flow | $14.6M | -82.8% |
| Free Cash Flow | -$246.0M | -0.9% |
| -18.4% |